News | June 21, 2011

French Cancer Center Doubles Patient Volume With VMAT Radiation Therapy Technique

June 21, 2011 – In just four years, Clinique Claude Bernard's Private Radiotherapy Center (PRCM, Metz, France) will have doubled the number of patients receiving radiation therapy treatments per year – from 1,100 to a predicted 2,200 patients by the end of this year. This achievement was enabled by equipping first one, then all three of its Elekta Synergy treatment systems with Elekta VMAT (volumetric modulated arc therapy). With VMAT, single or multiple radiation beams sweep in arc(s) around the patient, which can significantly reduce treatment times. On April 28, a patient with breast cancer became PRCM's 2,500th to receive VMAT since the clinic began using the technique in 2009.

"We treat all disease sites with VMAT, including palliative patients," said Guillaume Faure, M.D., co-director of radiation oncology at PRCM, the first center in France to use Elekta VMAT. "We started VMAT breast treatments last month and 37 patients per day are under treatment on one of our Synergy systems. Our early results show that VMAT increases homogeneity to the treated volume and reduces the irradiated lung volume. Skin reactions also are reduced since VMAT obviates the use of electron beams to treat the internal mammary lymph nodes, and precludes the use of radiation boost fields – which is the case for conventional 3-D conformal therapy and intensity modulated radiation therapy [IMRT] breast treatments."

For breast VMAT, treatment time in some cases is reduced by 20 percent, since radiation therapists don't have to re-enter the room to set up electron fields, he adds.

"Using VMAT also speeds up pre-treatment quality assurance, decreasing PRCM's staff workload when compared to IMRT, while reducing the source of errors by decreasing the number of beams to transfer and verify," said Romain Ruchaud, M.Sc., co-director of PRCM.

At PRCM, radiation therapy for a variety of disease sites now takes seconds to deliver rather than minutes:
• 102 seconds: head-and-neck
• 98 seconds: brain
• 81 seconds: rectum
• 79 seconds: prostate
• 79 seconds: lung
• 124 seconds: breast
• 61 seconds: metastases

Beyond treatment speed, VMAT offers patients with metastatic disease major quality of life advantages, according to Faure.

"Organ-at-risk sparing allows us to confidently employ hypofractionation schemes with no difference in toxicity, while reducing the number of treatment sessions and travel for the patient," stated Faure.

VMAT also has created new possibilities to emphasize treatment plan quality over speed.
"This can lead to delivery time increases of up to 30 percent and more dual arc treatment deliveries," Faure stated. "However, we are now approaching dose distributions that are comparable to helical tomotherapy, but with much greater workflow efficiency. On a daily basis, VMAT is enabling us to raise the quality of patient care."

Approval of indications may vary between different countries. Additional regulatory clearances may be required in some markets.

For more information: www.elekta.com

Related Content

SpaceOAR Hydrogel Now Available in Japan
News | Patient Positioning Radiation Therapy | July 16, 2018
Augmenix K.K. announced that SpaceOAR hydrogel, a soft, implanted absorbable gel spacer is now available to all...
RaySearch Releases New Version of RayCare OIS
Technology | Oncology Information Management Systems (OIMS) | July 13, 2018
RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
Bruce Power Joins Forces With ITM to Supply Lutetium-177 for Cancer Therapy
News | Radiation Therapy | July 11, 2018
Canadian nuclear power company Bruce Power and German-based Isotope Technologies Garching (ITG) signed an agreement to...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
Northern Centre for Cancer Care (NCCC)

Northern Centre for Cancer Care (NCCC).

Sponsored Content | Case Study | Radiation Therapy | July 05, 2018
Established in 2009, Northern Centre for Cancer Care (NCCC) is the largest center of its kind in the north of England....
Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Overlay Init